Hospital Clinico San Carlos; Servicio de Nefrologia

Madrid 28040

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Influenza, Human, NMO Spectrum Disorder (NMOSD), Neuromyelitis Optica (NMO)

Studies at this site

• Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) — Completed
• A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread — Stopped early
• A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants. — Completed